Expectancy effects cannot be neglected in MDMA-assisted therapy research
L. J. Flameling, Jacob S. Aday, Michiel van Elk 1 citation preprint
In their recent paper titled “MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial”, Mitchell et al.1 report on the results from a study researching the potential use of 3,4-methylenedioxy methamphetamine-assisted therapy (MDMA-AT) for the treatment of posttraumatic stress disorder (PTSD). We applaud the efforts made to further establish the efficacy...